Department of Geriatric Surgery, The First Affiliated Hospital of China Medical University, Shenyang, PR China.
Department of Hepatobiliary Surgery, The First Affiliated Hospital of China Medical University, Shenyang, PR China.
Cell Death Dis. 2019 Jun 13;10(6):465. doi: 10.1038/s41419-019-1712-0.
An increasing interest in liver cancer stemness arises owing to its aggressive behavior and poor prognosis. CD133, a widely known liver cancer stem cell marker, plays critical roles in the maintenance of liver cancer stemness. Thus, exploring the regulatory mechanism of CD133 expression is significant. In the present study, we proved the carcinogenesis roles of aquaporin 3 (AQP3) in hepatocellular carcinoma (HCC) and demonstrated that AQP3 promotes the stem cell-like properties of hepatoma cells by regulating CD133 expression. In addition, AQP3 promoted the stimulation and nuclear translocation of signal transducer and activator of transcription 3 (STAT3) with a subsequent increase in the level of CD133 promoter-acetylated histone H3. This phenomenon accelerated CD133 transcription. Next, whether AQP3 acted as an oncogenic gene in HCC and maintained the stemness of CD133+ hepatoma cells were elucidated; also, a novel mechanism underlying the AQP3/STAT3/CD133 pathway in HCC was deduced.
由于肝癌干细胞的侵袭性行为和不良预后,人们对肝癌干细胞特性的兴趣日益增加。CD133 是一种广泛认可的肝癌干细胞标志物,在维持肝癌干细胞特性方面发挥着关键作用。因此,探索 CD133 表达的调控机制具有重要意义。在本研究中,我们证明了水通道蛋白 3(AQP3)在肝细胞癌(HCC)中的致癌作用,并证实 AQP3 通过调节 CD133 的表达促进肝癌细胞的干细胞样特性。此外,AQP3 促进信号转导和转录激活因子 3(STAT3)的刺激和核易位,随后 CD133 启动子乙酰化组蛋白 H3 的水平增加。这种现象加速了 CD133 的转录。接下来,我们阐明了 AQP3 是否在 HCC 中作为致癌基因发挥作用,并维持 CD133+肝癌细胞的干细胞特性;还推断了 HCC 中 AQP3/STAT3/CD133 通路的新机制。